Cargando…
Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility
Isocitrate lyase (ICL), a potential anti-tubercular drug target, catalyzes the first step of the glyoxylate shunt. In the present investigation, we studied the conformational flexibility of MtbICL to better understand its stability and catalytic activity. Our biochemical results showed that a point...
Autores principales: | Shukla, Harish, Shukla, Rohit, Sonkar, Amit, Pandey, Tripti, Tripathi, Timir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430663/ https://www.ncbi.nlm.nih.gov/pubmed/28432345 http://dx.doi.org/10.1038/s41598-017-01235-z |
Ejemplares similares
-
Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase
por: Ibeji, Collins U., et al.
Publicado: (2020) -
Portrait of the Intrinsically Disordered Side of the HTLV-1 Proteome
por: Lyngdoh, Denzelle L., et al.
Publicado: (2019) -
Modulation of Central Carbon Metabolism by Acetylation of Isocitrate Lyase in Mycobacterium tuberculosis
por: Bi, Jing, et al.
Publicado: (2017) -
Discovery of a Novel Inhibitor Structure of Mycobacterium tuberculosis Isocitrate Lyase
por: Duan, Changyuan, et al.
Publicado: (2022) -
Acetyl-CoA-mediated activation of Mycobacterium tuberculosis isocitrate lyase 2
por: Bhusal, Ram Prasad, et al.
Publicado: (2019)